• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[头颈部鳞状细胞癌的放射治疗:现状与未来方向]

[Radiotherapy for head and neck squamous cell carcinoma: State of the art and future directions].

作者信息

Schick U, Huguet F, Pointreau Y, Pradier O

机构信息

Service de radiothérapie, institut de cancérologie et d'hématologie, CHRU Morvan, 2, avenue Foch, 29200 Brest, France.

Service d'oncologie radiothérapie, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France; Université Paris 6, 4, rue de la Chine, 75020 Paris, France.

出版信息

Cancer Radiother. 2017 Oct;21(6-7):498-504. doi: 10.1016/j.canrad.2017.07.032. Epub 2017 Aug 31.

DOI:10.1016/j.canrad.2017.07.032
PMID:28864046
Abstract

Therapeutic principles of radiation therapy in head and neck carcinomas will be discussed in this review. Intensity-modulated radiotherapy with concomitant cisplatin should be standard. In case of contraindication to chemotherapy, cetuximab is an option, while hyperfractionation should be considered in patients unfit for concomitant treatment. Concomitant chemotherapy should be administered in the presence of extracapsular extensions and positive margins in the postoperative setting. Current research areas such as desescalation in human papillomavirus-positive tumours, adaptive radiotherapy, radiomics and immunotherapy will also be addressed.

摘要

本综述将讨论头颈部癌放射治疗的治疗原则。调强放疗联合顺铂应成为标准治疗方案。若存在化疗禁忌证,西妥昔单抗是一种选择,而对于不适合同步治疗的患者应考虑超分割放疗。术后出现包膜外扩展和切缘阳性时应给予同步化疗。当前的研究领域,如人乳头瘤病毒阳性肿瘤的降阶梯治疗、自适应放疗、放射组学和免疫治疗也将予以探讨。

相似文献

1
[Radiotherapy for head and neck squamous cell carcinoma: State of the art and future directions].[头颈部鳞状细胞癌的放射治疗:现状与未来方向]
Cancer Radiother. 2017 Oct;21(6-7):498-504. doi: 10.1016/j.canrad.2017.07.032. Epub 2017 Aug 31.
2
[Postoperative radiotherapy with cetuximab for head and neck squamous cell carcinoma patients at high risk of recurrence not eligible for cisplatin: A single-center experience and literature review].[西妥昔单抗用于无法使用顺铂的复发高危头颈鳞状细胞癌患者的术后放疗:单中心经验及文献综述]
Cancer Radiother. 2023 Feb;27(1):17-22. doi: 10.1016/j.canrad.2022.04.008. Epub 2022 Jul 16.
3
Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.随机对照试验比较手术和辅助放疗与同期放化疗治疗晚期局部非转移性头颈部鳞状细胞癌患者:10 年更新和亚组分析。
Cancer. 2015 May 15;121(10):1599-607. doi: 10.1002/cncr.29251. Epub 2015 Jan 29.
4
Postoperative reduced dose of cisplatin concomitant with radiation therapy in high- risk head and neck squamous cell carcinoma.高危头颈部鳞状细胞癌术后低剂量顺铂同步放疗
Cancer. 2009 Jun 1;115(11):2464-71. doi: 10.1002/cncr.24252.
5
Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma.高危头颈部鳞状细胞癌的术后放化疗
Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):365-73. doi: 10.1016/j.ijrobp.2004.03.011.
6
RTOG 0522: a randomized phase III trial of concurrent accelerated radiation and cisplatin versus concurrent accelerated radiation, cisplatin, and cetuximab [followed by surgery for selected patients] for Stage III and IV head and neck carcinomas.RTOG 0522:一项针对III期和IV期头颈癌的随机III期试验,比较同步加速放疗和顺铂与同步加速放疗、顺铂和西妥昔单抗(随后为部分患者进行手术)的疗效。
Clin Adv Hematol Oncol. 2007 Feb;5(2):79-81.
7
Advanced Squamous Cell Carcinoma of the Head and Neck: The Current Role of Cetuximab.头颈部晚期鳞状细胞癌:西妥昔单抗的当前作用
ORL J Otorhinolaryngol Relat Spec. 2016;78(6):320-333. doi: 10.1159/000455891. Epub 2017 Jan 27.
8
The Role of Radiotherapy in the Definitive and Postoperative Treatment of Advanced Head and Neck Cancer.放疗在晚期头颈部癌症的根治性和术后治疗中的作用。
Oncol Res Treat. 2017;40(6):347-352. doi: 10.1159/000477128. Epub 2017 May 17.
9
[Treatment of squamous cell carcinoma of the head and neck with multi-drug chemotherapy and radiotherapy].头颈部鳞状细胞癌的多药化疗与放疗治疗
Gan To Kagaku Ryoho. 1989 Sep;16(9):3111-8.
10
Induction chemotherapy with docetaxel, cisplatin and capecitabine, followed by combined cetuximab and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck: a phase I-II study.多西他赛、顺铂和卡培他滨诱导化疗,随后联合西妥昔单抗和放疗治疗局部晚期不可手术的头颈部鳞状细胞癌患者:一项 I-II 期研究。
Oncology. 2013;84(4):251-4. doi: 10.1159/000347232. Epub 2013 Feb 20.

引用本文的文献

1
Differential modulation of PI3K/Akt/mTOR activity by EGFR inhibitors: A rationale for co-targeting EGFR and PI3K in cisplatin-resistant HNSCC.表皮生长因子受体抑制剂对 PI3K/Akt/mTOR 活性的差异调节:顺铂耐药头颈部鳞状细胞癌中共同靶向 EGFR 和 PI3K 的原理。
Head Neck. 2024 May;46(5):1126-1135. doi: 10.1002/hed.27718. Epub 2024 Mar 1.
2
Preliminary clinical outcomes of head and neck squamous cell carcinoma treated with particle beam radiation therapy.采用粒子束放射疗法治疗头颈部鳞状细胞癌的初步临床结果。
Cancer Med. 2023 Jun;12(11):12128-12138. doi: 10.1002/cam4.5902. Epub 2023 Apr 11.
3
Inhibition of IKKβ/NF-κB signaling pathway to improve Dasatinib efficacy in suppression of cisplatin-resistant head and neck squamous cell carcinoma.
抑制IKKβ/NF-κB信号通路以提高达沙替尼对顺铂耐药头颈部鳞状细胞癌的抑制效果。
Cell Death Discov. 2020 May 15;6:36. doi: 10.1038/s41420-020-0270-7. eCollection 2020.
4
Impact of thoracic radiation therapy after chemotherapy on survival in extensive-stage small cell lung cancer: A propensity score-matched analysis.化疗后胸部放疗对广泛期小细胞肺癌生存的影响:倾向评分匹配分析。
Thorac Cancer. 2019 Apr;10(4):799-806. doi: 10.1111/1759-7714.13001. Epub 2019 Feb 18.
5
Genetics and management of locally advanced carcinomas of the head and neck: role of altered fractionation radiotherapy.头颈部局部晚期癌的遗传学与管理:超分割放疗的作用
Future Sci OA. 2018 Oct 26;5(1):FSO347. doi: 10.4155/fsoa-2018-0058. eCollection 2019 Jan.